Analystreport

Myriad Genetics (NASDAQ:MYGN) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Myriad Genetics, Inc.  (MYGN) 
Last myriad genetics, inc. earnings: 2/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: myriad.com/news-center/investor-information